High-resolution mass spectrometry provides novel

3 downloads 0 Views 3MB Size Report
Dec 27, 2014 - with the separation power of ultrahigh-performance liquid chro- matography were ... application of alternative FRs to meet fire safety regulations. Currently, very ... HBCD, respectively), a fairly low vapor pressure (6.27×. 10. −5. Pa) and .... Chromatographic analysis was achieved using a dual pump. Ultimate ...
Anal Bioanal Chem DOI 10.1007/s00216-015-8466-z

RESEARCH PAPER

High-resolution mass spectrometry provides novel insights into products of human metabolism of organophosphate and brominated flame retardants Mohamed Abou-Elwafa Abdallah & Jinkang Zhang & Gopal Pawar & Mark R. Viant & J. Kevin Chipman & Kyle D’Silva & Maciej Bromirski & Stuart Harrad

Received: 14 November 2014 / Revised: 27 December 2014 / Accepted: 5 January 2015 # Springer-Verlag Berlin Heidelberg 2015

Abstract The high resolution, accurate mass, and fast scanning features of the OrbitrapTM mass spectrometer, combined with the separation power of ultrahigh-performance liquid chromatography were applied for the first time to study the metabolic profiles of several organic flame retardants (FRs) present in indoor dust. To mimic real-life exposure, in vitro cultured HepG2 human hepatocyte cell lines were exposed simultaneously to various FRs in an indoor dust extract for 24 h. Target parent FRs, hexabromocyclododecanes (α-, β-, and γ-HBCDs), tris-2-chloroethyl phosphate (TCEP), tris(1chloro-2-propyl) phosphate (TCIPP), and tris(1,3-dichloro-2propyl) phosphate (TDCIPP), were separated in a single run for the first time using alternating positive and negative heated ESI source. Further metabolite separation and identification

was achieved using full scan (70,000 full width at half maximum (FWHM)), accurate mass (up to 1 ppm) spectrometry. Structural confirmation was performed via all ion fragmentation (AIF) spectra using the optional higher collisional dissociation (HCD) cell and MS/MS analysis. First insights into human metabolism of HBCDs revealed several hydroxylated and debrominated phase I metabolites, in addition to conjugated phase II glucuronides. Furthermore, various hydroxylated, oxidized, and conjugated metabolites of chlorinated phosphorous FRs were identified, leading to the suggestion of α-oxidation as a significant metabolic pathway for these compounds. Keywords High-resolution mass spectrometry . Orbitrap . Metabolism . Indoor dust . HBCD . Organophosphate flame retardants

Electronic supplementary material The online version of this article (doi:10.1007/s00216-015-8466-z) contains supplementary material, which is available to authorized users. M. A.66 %) and tris(1chloropropyl) phosphate (∼30 %). The formation of two BCIPP isomers was attributed to exposure of the microsomes to two TCIPP isomers [13]. Therefore, the detection of one

M.A.-E. Abdallah et al. Table 3

Metabolic profile of TCIPP by human HepG2 cell lines

BCIPP isomer following exposure of human HepG2 cells to D2 can be attributed to the presence of pure tris(1chloro-2-propyl) phosphate in the Wellington® standard for TCIPP, which was used to prepare the dosing mixture D2 in this study. Furthermore, a hydroxylated metabolite, bis(1-chloro-2propyl) hydroxy 2-propyl phosphate (TCEP-M1), and a

carboxylic acid, bis(1-chloro-2-propyl) carboxy 2-ethyl phosphate (TCEP-M2), were also identified (Table 3). This suggests that α-oxidation (Fig. 5) may constitute a major metabolic pathway for TCIPP in human hepatocytes. As a result of phase II metabolism, the glutathione conjugate of TCIPP was identified (Table 3). However, no glucuronide or sulfate conjugates could be confirmed.

Orbitrap™-MS provides novel insights into pollutants metabolism Table 4

Metabolic profile of TDCIPP by human HepG2 cell lines

TDCIPP metabolic profile Biotransformation of TDCIPP in indoor dust by human hepatocytes followed a similar profile to that observed for TCEP

and TCIPP (Table 4). The diester, bis(1,3-dichloro-2-propyl) hydrogen phosphate (BDCIPP), was the major metabolite formed after 24 h of exposure (based on the relative peak area to that of the parent TDCIPP). This is in agreement with a

M.A.-E. Abdallah et al.

previous in vivo study, which reported BDCIPP as the major urinary, fecal and biliary metabolite in rats following intravenous administration of radiolabeled TDCIPP [37]. Another in vitro study also reported BDCIPP as the major metabolite of TDCIPP by human liver microsomes [13]. In addition to the hydroxylated metabolite (TDCIPP-M1) and the carboxylic acid metabolite (TDCIPP-M2), the monoester, 1,3-dichloro-2propyl dihydrogen phosphate (DCIPP), was also identified (Table 4). Further hydrolysis of BDCIPP by esterases was previously suggested following in vitro incubation of TDCIPP with human liver microsomes [38]. The glutathione conjugate of TDCIPP was identified as a result of phase II metabolism (Table 4). This is in agreement with the results of previous in vitro studies using human liver microsomes [13, 38].

Conclusion A novel multi-residue analytical method was developed and applied to study the metabolic products formed when human HepG2 cell lines were challenged simultaneously—for the first time—with several widely used organic flame retardants present in indoor dust. To mimic real-life exposure scenarios, human hepatocytes were concomitantly exposed for 24 h to αHBCD, β-HBCD, γ-HBCD, TCEP, TCIPP, and TDCIPP extracted from indoor dust. To identify the large number of metabolites formed, an ExactiveTM Plus OrbitrapTM highresolution mass spectrometer was applied following chromatographic separation via UPLC. For the first time, target parent compounds were separated and monitored in a single run using an alternating positive and negative heated ESI source. Further metabolite separation and identification was performed using the high-resolution (70,000 FWHM) accurate mass (up to 1 ppm) features of the OrbitrapTM-MS. Structural confirmation of the detected metabolites was achieved via all ion fragmentation (AIF) spectra using the optional higher collisional dissociation (HCD) cell of the MS. Hepatic metabolism of HBCDs in human was investigated for the first time. Several hydroxylated and debrominated phase I metabolites were identified, while conjugated phase II glucuronides of HBCDs were also confirmed. Hydroxylated, oxidized, and conjugated metabolites of chlorinated phosphorous flame retardants were also observed, and αoxidation was proposed as a metabolic pathway for target PFRs in human hepatocytes. Acknowledgments The research leading to these results has received funding from the European Union Seventh Framework Programme FP7/ 2007-2013 under grant agreements PIIF-GA-2012-327232 (ADAPT project), 316665 (A-TEAM project), and 264600 (INFLAME project).

References 1. Lokke H, Ragas AMJ, Holmstrup M (2013) Tools and perspectives for assessing chemical mixtures and multiple stressors. Toxicology 313(2–3):73–82. doi:10.1016/j.tox.2012.11.009 2. Trudel D, Scheringer M, von Goetz N, Hungerbuehler K (2011) Total consumer exposure to polybrominated diphenyl ethers in North America and Europe. Environ Sci Technol 45(6):2391–2397. doi: 10.1021/es1035046 3. Cao ZG, Xu FC, Covaci A, Wu M, Wang HZ, Yu G, Wang B, Deng SB, Huang J, Wang XY (2014) Distribution patterns of brominated, chlorinated, and phosphorus flame retardants with particle size in indoor and outdoor dust and implications for human exposure. Environ Sci Technol 48(15):8839–8846. doi:10.1021/es501224b 4. Hakk H, Letcher RJ (2003) Metabolism in the toxicokinetics and fate of brominated flame retardants—a review. Environ Int 29(6):801– 828 5. Browne EP, Stapleton HM, Kelly SM, Tilton SC, Gallagher EP (2009) In vitro hepatic metabolism of 2,2 ',4,4 ',5pentabromodiphenyl ether (BDE 99) in Chinook Salmon (Onchorhynchus tshawytscha). Aquat Toxicol 92(4):281–287. doi: 10.1016/j.aquatox.2009.02.017 6. Stapleton HM, Kelly SM, Pei R, Letcher RJ, Gunsch C (2009) Metabolism of polybrominated diphenyl ethers (PBDEs) by human hepatocytes in vitro. Environ Health Perspect 117(2):197–202. doi: 10.1289/ehp.11807 7. United Nations Environment Programme (UNEP) (2014) Persistent Organic Pollutants Review Committee (POPRC), Reports and Decisions. http://chm.pops.int/TheConvention/POPsReviewCommittee/ OverviewandMandate/tabid/2806/Default.aspx 8. van der Veen I, de Boer J (2012) Phosphorus flame retardants: properties, production, environmental occurrence, toxicity and analysis. Chemosphere 88(10):1119–1153. doi:10.1016/j.chemosphere.2012. 03.067 9. Regnery J, Puettmann W, Merz C, Berthold G (2011) Occurrence and distribution of organophosphorus flame retardants and plasticizers in anthropogenically affected groundwater. J Environ Monitor 13(2): 347–354. doi:10.1039/c0em00419g 10. Regnery J, Puttmann W (2010) Occurrence and fate of organophosphorus flame retardants and plasticizers in urban and remote surface waters in Germany. Water Res 44(14):4097–4104. doi:10.1016/j. watres.2010.05.024 11. ECHA (2010) European Chemicals Agency: Annex1-Document to RAC opinion on TDCP. http://echaeuropa.eu/documents/10162/ 0410f4e3-7838-4819-b321-f9d75d3a9cce (accessed 19-6-2012) 12. Environmental Health Criteria (1995) Tetrabromobisphenol A and derivatives. International Programme on Chemical Safety World Health Organization, Geneva, 172 13. Van den Eede N, Maho W, Erratico C, Neels H, Covaci A (2013) First insights in the metabolism of phosphate flame retardants and plasticizers using human liver fractions. Toxicol Lett 223(1):9–15. doi:10.1016/j.toxlet.2013.08.012 14. KEMI (2007) National Chemicals Inspectorate, EU Risk Assessment Report on Hexabromocyclododecane R044_0710_env_hh.doc. R044_0710_env_hhdoc; Sundbyberg, Sweden 15. Marvin CH, Tomy GT, Armitage JM, Arnot JA, McCarty L, Covaci A, Palace V (2011) Hexabromocyclododecane: current understanding of chemistry, environmental fate and toxicology and implications for global management. Environ Sci Technol 45(20):8613–8623. doi: 10.1021/es201548c 16. Abdallah MA-E, Uchea C, Chipman JK, Harrad S (2014) Enantioselective biotransformation of hexabromocyclododecane by in vitro rat and trout hepatic sub-cellular fractions. Environ Sci Technol 48(5):2732–2740. doi:10.1021/es404644s

Orbitrap™-MS provides novel insights into pollutants metabolism 17. Brandsma SH, van der Ven LTM, de Boer J, Leonards PEG (2009) Identification of hydroxylated metabolites of hexabromocyclododecane in wildlife and 28-days exposed wistar rats. Environ Sci Technol 43(15):6058–6063. doi:10.1021/es900879k 18. Hakk H, Szabo DT, Huwe J, Diliberto J, Birnbaum LS (2012) Novel and distinct metabolites identified following a single oral dose of alpha- or gamma-hexabromocyclododecane in mice. Environ Sci Technol 46(24):13494–13503. doi:10.1021/es303209g 19. Werner E, Croixmarie V, Umbdenstock T, Ezan E, Chaminade P, Tabet JC, Junot C (2008) Mass spectrometry-based metabolomics: accelerating the characterization of discriminating signals by combining statistical correlations and ultrahigh resolution. Anal Chem 80(13):4918–4932. doi:10.1021/Ac800094p 20. Alves A, Kucharska A, Erratico C, Xu FC, Den Hond E, Koppen G, Vanermen G, Covaci A, Voorspoels S (2014) Human biomonitoring of emerging pollutants through non-invasive matrices: state of the art and future potential. Anal Bioanal Chem 406(17):4063–4088. doi:10. 1007/s00216-014-7748-1 21. Bandele OJ, Santillo MF, Ferguson M, Wiesenfeld PL (2012) In vitro toxicity screening of chemical mixtures using HepG2/C3A cells. Food Chem Toxicol 50(5):1653–1659. doi:10.1016/j.fct.2012.02. 016 22. Flynn TJ, Ferguson MS (2008) Multiendpoint mechanistic profiling of hepatotoxicants in HepG2/C3A human hepatoma cells and novel statistical approaches for development of a prediction model for acute hepatotoxicity. Toxicol in Vitro 22(6):1618–1631. doi:10.1016/j.tiv. 2008.04.016 23. Kelly JH, Sussman NL (2000) A fluorescent cell-based assay for cytochrome P-450 isozyme 1A2 induction and inhibition. J Biomol Screen 5(4):249–253. doi:10.1089/108705700416119 24. Jones-Otazo HA, Clarke JP, Diamond ML, Archbold JA, Ferguson G, Harner T, Richardson GM, Ryan JJ, Wilford B (2005) Is house dust the missing exposure pathway for PBDEs? An analysis of the urban fate and human exposure to PBDEs. Environ Sci Technol 39(14):5121–5130 25. Harrad S, Abdallah MA-E (2011) Brominated flame retardants in dust from UK cars—within-vehicle spatial variability, evidence for degradation and exposure implications. Chemosphere 82(9):1240– 1245. doi:10.1016/j.chemosphere.2010.12.038 26. Abdallah MA, Harrad S (2009) Personal exposure to HBCDs and its degradation products via ingestion of indoor dust. Environ Int 35(6): 870–876. doi:10.1016/j.envint.2009.03.002 27. Abdallah MA, Harrad S (2011) Tetrabromobisphenol-A, hexabromocyclododecane and its degradation products in UK

human milk: relationship to external exposure. Environ Int 37(2): 443–448. doi:10.1016/j.envint.2010.11.008 28. Carignan CC, Abdallah MA, Wu N, Heiger-Bernays W, McClean M D , H a r r a d S , We b s t e r T F ( 2 0 1 2 ) P r e d i c t o r s o f tetrabromobisphenol-A (TBBP-A) and hexabromocyclododecanes (HBCD) in milk from Boston mothers. Environ Sci Technol 46(21):12146–12153. doi:10.1021/es302638d 29. Esslinger S , Becker R , M aul R, N ehls I (2011) Hexabromocyclododecane enantiomers: microsomal degradation and patterns of hydroxylated metabolites. Environ Sci Technol 45(9):3938–3944. doi:10.1021/es1039584 30. Benedict RT, Stapleton HM, Letcher RJ, Mitchelmore CL (2007) Debromination of polybrominated diphenyl ether-99 (BDE-99) in carp (Cyprinus carpio) microflora and microsomes. Chemosphere 69(6):987–993. doi:10.1016/j.chemosphere.2007.05.010 31. Butt CM, Wang D, Stapleton HM (2011) Halogenated phenolic contaminants inhibit the in vitro activity of the thyroid regulating deiodinases in human liver. Toxicol Sci. doi:10.1093/toxsci/kfr117 32. Szabo DT, Richardson VM, Ross DG, Diliberto JJ, Kodavanti PRS, Birnbaum LS (2009) Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups. Toxicol Sci 107(1):27–39 33. Holcapek M, Kolarova L, Nobilis M (2008) High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites. Anal Bioanal Chem 391(1):59–78. doi:10.1007/s00216-008-1962-7 34. Burka LT, Sanders JM, Herr DW, Matthews HB (1991) Metabolism of tris(2-chloroethyl) phosphate in rats and mice. Drug Metab Dispos 19(2):443–447 35. Chapman DE, Michener SR, Powis G (1991) Metabolism of the flame-retardant plasticizer tris(2-chloroethyl)phosphate by human and rat-liver preparations. Fundam Appl Toxicol 17(2):215–224. doi:10.1016/0272-0590(91)90214-o 36. Stubbings WA, Harrad S (2014) Extent and mechanisms of brominated flame retardant emissions from waste soft furnishings and fabrics: a critical review. Environ Int 71:164–175. doi:10.1016/j.envint. 2014.06.007 37. Lynn RK, Wong K, Garviegould C, Kennish JM (1981) Disposition of the flame-retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat. Drug Metab Dispos 9(5):434–441 38. Cooper E, Stapleton H (2011) Metabolism of organophosphate flame retardants by human liver microsomes and porcine esterase. SETAC North America 32nd Annual Meeting http://orbit.dtu.dk/fedora/ objects/orbit:105810/datastreams/file_6352082/content:176